LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma
Details
Serval ID
serval:BIB_AA7296087B5B
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma
Journal
Annals of Oncology
ISSN
0923-7534
Publication state
Published
Issued date
09/2021
Volume
32
Pages
S1308
Language
english
Keywords
Oncology, Hematology
Web of science
Open Access
Yes
Create date
12/01/2022 10:26
Last modification date
13/01/2022 6:33